​Dr. Chris Apfel is the President and CEO of SageMedic Corp.  He co-founded SageMedic with his wife, Dr. Brigitte Apfel, after several of their family members were touched by cancer.  Chris is a physician-scientist, board member, and an active angel investor and of over a dozen early stage life-science companies.  He is recognized as an international authority on designing, conducting, and publishing clinical trials that have changed medical practice. For example, he is the developer of the “Apfel Score,” a standard tool that has changed clinical practice world-wide.  He is a California-licensed physician and received his MD and his doctoral degree in medical sciences from the University of Giessen, Germany, and his MBA from Wharton, University of Pennsylvania.

Co-Founder and President & CEO

Melissa Ross, MBA

Melissa Ross is SVP of Business Operations at SageMedic.  An accomplished senior executive with a 25-year track record of growing healthcare information technology companies, she was previously the Chief Operating Officer of VisiQuate.  Prior to that she co-founded the Bishop Ranch Intelligence Innovation Accelerator (BRIIA).  Before that she held several leadership positions as a VP at MedeAnalytics, where she helped the company grow from a start-up to over $115 million in annual revenues.  Melissa holds a BS in Mathematics from Loyola University Maryland and an MBA from Saint Mary’s College of California.

Senior Vice President

Mona Wood, MD, PhD

Dr. Mona Wood is the medical lab director overseeing quality control and establishing SageMedic's CLIA certification. As a Stanford-trained Pathologist, she has over 15 years of experience in biomedical research in a variety of scientific fields including gene therapy, protein structure and computational chemistry. She has earned numerous research awards and grants, including an independent early-investigator training award from NIH’s National Cancer Institute.  Dr. Wood has served as an elected chief resident in pathology informatics for two academic years at Stanford and is a graduate of Stanford’s Biodesign Innovation course. She majored in Chemistry, Biochemistry and French at the University of Michigan and received her MD and PhD in Chemistry from the University of California, Irvine.

Medical Lab Director

Brigitte Apfel, MD

Dr. Brigitte Apfel, Co-Founder and Treasurer of SageMedic, is a pulmonologist who treated many lung cancer patients.  When she and her husband moved to the Bay Area, she became a UCSF-trained psychiatrist.  When family members were affected by cancer, she and her husband co-founded SageMedic.  Brigitte received her MD from the Ruprecht Karl University of Heidelberg in Germany.

Co-Founder & Treasurer

William Werkmeister, MPA, MBA

Bill is a Founding Partner of the International Cancer Impact Fund and currently serves on the Advisory Board of the National Foundation for Cancer Research. Bill also co-founded a mobile breast tomosynthesis business.  In addition, he started a series of state-subsidized impact venture funds called Aegis Venture and served as AVP of Newtek/The Wilshire Group’s venture funds. Earlier in his career, Bill was an investment banker at Salomon Smith Barney and Citigroup Global Markets. Bill holds a BS in Finance from Cornell, an MPA from Harvard, and an MBA from Yale.

Board Director

Bernard Rudnick

Mr. Rudnick is the founder and Managing Partner of CapGenic Advisors, LLC, Chief Business Officer of NovoBioPharma, and a member of several angel groups. Mr. Rudnick’s entrepreneurial career includes several start-ups, three of which grew to over $60 million in revenue. He is a founder of one of the nation’s leading entrepreneurial programs (MADV) at the Fox School of Business, a director of Otosound, director and CFO of Immunomic Therapeutics, and has held several other board positions.  With over 30 years of experience in executive-level strategy, finance, and management, Mr. Rudnick has senior merger, acquisition, capital formation and licensing leadership experience with companies ranging from start-up to Fortune 50. Mr. Rudnick currently advises companies in clinical software, therapeutic, medical device, and cell line engineering areas. His angel group affiliations include Minority Angel Investment Network, a founder of Mid-Atlantic Bio Angels and Keiretsu Mid-Atlantic.

Board Director

Please reload

This website is not for investment purposes. Contact the company for investing documents.

Copyright © 2019 SageMedic Corporation. All rights reserved.